Cargando…
CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X
Current antiviral therapies cannot cure hepatitis B virus (HBV) infection; successful HBV eradication would require inactivation of the viral genome, which primarily persists in host cells as episomal covalently closed circular DNA (cccDNA) and, to a lesser extent, as chromosomally integrated sequen...
Autores principales: | Karimova, Madina, Beschorner, Niklas, Dammermann, Werner, Chemnitz, Jan, Indenbirken, Daniela, Bockmann, Jan-Hendrik, Grundhoff, Adam, Lüth, Stefan, Buchholz, Frank, Wiesch, Julian Schulze zur, Hauber, Joachim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558539/ https://www.ncbi.nlm.nih.gov/pubmed/26334116 http://dx.doi.org/10.1038/srep13734 |
Ejemplares similares
-
Next-generation LTR-specific Tre-recombinase targets a majority of HIV-1 isolates
por: Hauber, Joachim, et al.
Publicado: (2014) -
Development of a novel IGRA assay to test T cell responsiveness to HBV antigens in whole blood of chronic Hepatitis B patients
por: Dammermann, Werner, et al.
Publicado: (2015) -
High Rates of Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Metabolic and Cardiovascular Comorbidities
por: Bockmann, Jan-Hendrik, et al.
Publicado: (2021) -
Increased Expression of Complement Regulators CD55 and CD59 on Peripheral Blood Cells in Patients with EAHEC O104:H4 Infection
por: Dammermann, Werner, et al.
Publicado: (2013) -
Targeted Large-Scale Deletion of Bacterial Genomes
Using CRISPR-Nickases
por: Standage-Beier, Kylie, et al.
Publicado: (2015)